IPIC Message Board - Msg: 5624638

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WeirdPro Randy who wrote (1262)	8/30/1998 7:01:00 AM
From: jlib	Read Replies (1) of 1359

In all of this, why has no one gone back to Michael Weintraub's patients of the late 80's-early 90's whose participation in a four year study first proved the effectiveness of the fen-phen combination? It seems they would be the most fruitful group to investigate for any long term effects. Wurtman's protestation that "They should never have been prescribed together" is a bit disingenuous. Does anyone remember IPIC releasing any memos to physicians discouraging that use? Also, even if we bracket out the fact that both Wurtman and the coauthor are on IPIC's payroll, his attempt to label phentermine and such things as Sudafed as effective MAO inhibitors in humans at common dosage levels is simply not credible. Best, Jimmy Liberato

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next